Taiwan Vaccine’s Push For Acceptance

Reporter/Provider - Asnaya Chou and Sandy Chi

class="meta mb-0">Publish Date - 2021-12-14T18:05:42Z0 views

Taiwan’s homegrown vaccine has completed the latest phase of its medical trials, pushing it closer to international acceptance. On Monday, Medigen announced the completion of Phase 3 trials in Paraguay. The vaccine was rolled out for public use in Taiwan in August, but along with fighting variants, Medigen is also battling skepticism and questions about a lack of data.

We value your privacy.

We use cookies to analyze the traffic of TaiwanPlus to improve our service. Click here to find out more about TaiwanPlus's privacy policy.

Learn more Got it

Like what you see?

Download TaiwanPlus App now!

Download